THC Therapeutics Financials
| THCT Stock | USD 0.0005 0 89.13% |
THC |
Understanding current and past THC Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of THC Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in THC Therapeutics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in THC Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of THC Therapeutics. Check THC Therapeutics' Beneish M Score to see the likelihood of THC Therapeutics' management manipulating its earnings.
THC Therapeutics Stock Summary
THC Therapeutics competes with Brainsway, Venus Concept, Tactile Systems, Icecure Medical, and SurModics. It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. THC Therapeutics, Inc. was incorporated in 2007 and is based in Las Vegas, Nevada. Thc Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 11700 W Charleston |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | thct.io |
| Phone | 833 420 8428 |
| Currency | USD - US Dollar |
THC Therapeutics Key Financial Ratios
THC Therapeutics' financial ratios allow both analysts and investors to convert raw data from THC Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of THC Therapeutics over time and compare it to other companies across industries.| Return On Asset | -5.57 | |||
| Beta | 1.71 | |||
| Z Score | -6.0 |
THC Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining THC Therapeutics's current stock value. Our valuation model uses many indicators to compare THC Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across THC Therapeutics competition to find correlations between indicators driving THC Therapeutics's intrinsic value. More Info.THC Therapeutics is rated below average in return on asset category among its peers. It is rated below average in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the THC Therapeutics' earnings, one of the primary drivers of an investment's value.THC Therapeutics Systematic Risk
THC Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. THC Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on THC Therapeutics correlated with the market. If Beta is less than 0 THC Therapeutics generally moves in the opposite direction as compared to the market. If THC Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one THC Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of THC Therapeutics is generally in the same direction as the market. If Beta > 1 THC Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
THC Therapeutics November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of THC Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of THC Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of THC Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing THC Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build THC Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | 0.0975 | |||
| Maximum Drawdown | 889.13 |
Additional Tools for THC Pink Sheet Analysis
When running THC Therapeutics' price analysis, check to measure THC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Therapeutics is operating at the current time. Most of THC Therapeutics' value examination focuses on studying past and present price action to predict the probability of THC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Therapeutics' price. Additionally, you may evaluate how the addition of THC Therapeutics to your portfolios can decrease your overall portfolio volatility.